{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T08:28:49Z","timestamp":1750408129696,"version":"3.40.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated the clinical significance of loss of spleen visualization (LSV) on whole-body diffusion-weighted imaging (WB-DWI) in patients with multiple myeloma (MM). The WB-DWI of 96 patients with newly diagnosed MM (NDMM) and 15 patients with smoldering MM (sMM) were retrospectively reviewed. LSV was observed in 56 patients with NDMM (58.3%) and 1 patient with sMM (6.7%). Patients with NDMM with LSV had a higher median infiltration of bone marrow plasma cells (80.0% vs. 50.0%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and median total diffusion volume (median; 540.2 vs. 137.0\u00a0mL, <jats:italic>p<\/jats:italic>\u2009=\u20090.003) than patients without LSV. Patients with LSV had a lower spleen-to-spinal cord ratio (0.36 vs. 0.96, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and worse 2-year overall survival (OS) (84.6% vs. 100%, <jats:italic>p<\/jats:italic>\u2009=\u20090.032). Patients who did not recover spleen visualization during treatment had a worse prognosis, even when they obtained very good partial response (median progression-free survival: 13.2\u00a0months). Spleen histopathological findings revealed higher cellularity and diffuse myeloma cell infiltration in a patient with LSV and splenic amyloidosis without extramedullary hematopoiesis in a patient without LSV. Therefore, LSV indicates worse prognosis for patients with MM, even when the patient responds to treatment. Further studies are warranted to clarify the immunological role of spleen in MM.<\/jats:p>","DOI":"10.1038\/s41598-021-03496-1","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:03:55Z","timestamp":1639479835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6728-3346","authenticated-orcid":false,"given":"Toshiki","family":"Terao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youichi","family":"Machida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Kuzume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"3496_CR1","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/leu.2015.338","volume":"30","author":"C Pawlyn","year":"2016","unstructured":"Pawlyn, C. et al. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?. Leukemia 30, 1446\u20131448. https:\/\/doi.org\/10.1038\/leu.2015.338 (2016).","journal-title":"Leukemia"},{"key":"3496_CR2","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/s1470-2045(19)30309-2","volume":"20","author":"J Hillengass","year":"2019","unstructured":"Hillengass, J. et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 20, e302\u2013e312. https:\/\/doi.org\/10.1016\/s1470-2045(19)30309-2 (2019).","journal-title":"Lancet Oncol."},{"key":"3496_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/s41375-018-0329-0","volume":"33","author":"L Rasche","year":"2019","unstructured":"Rasche, L. et al. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma. Leukemia 33, 1713\u20131722. https:\/\/doi.org\/10.1038\/s41375-018-0329-0 (2019).","journal-title":"Leukemia"},{"key":"3496_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.crad.2015.02.013","volume":"70","author":"SL Giles","year":"2015","unstructured":"Giles, S. L. et al. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: Comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden. Clin. Radiol. 70, 614\u2013621. https:\/\/doi.org\/10.1016\/j.crad.2015.02.013 (2015).","journal-title":"Clin. Radiol."},{"key":"3496_CR5","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1007\/s00277-020-04265-2","volume":"99","author":"C Mesguich","year":"2020","unstructured":"Mesguich, C. et al. Prospective comparison of 18-FDG PET\/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma. Ann. Hematol. 99, 2869\u20132880. https:\/\/doi.org\/10.1007\/s00277-020-04265-2 (2020).","journal-title":"Ann. Hematol."},{"key":"3496_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05182-2","author":"O Westerland","year":"2021","unstructured":"Westerland, O. et al. Comparison of the diagnostic performance and impact on management of 18F-FDG PET\/CT and whole-body MRI in multiple myeloma. Eur. J. Nucl. Med. Mol. Imag. https:\/\/doi.org\/10.1007\/s00259-020-05182-2 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"3496_CR7","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1200\/edbk_159074","volume":"35","author":"E Terpos","year":"2016","unstructured":"Terpos, E., Dimopoulos, M. A. & Moulopoulos, L. A. The role of imaging in the treatment of patients with multiple myeloma in 2016. Am. Soc. Clin. Oncol. Educ. Book 35, e407-417. https:\/\/doi.org\/10.1200\/edbk_159074 (2016).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"3496_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou, C. et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: Myeloma response assessment and diagnosis system (MY-RADS). Radiology 291, 5\u201313. https:\/\/doi.org\/10.1148\/radiol.2019181949 (2019).","journal-title":"Radiology"},{"key":"3496_CR9","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1002\/cam4.4136","volume":"10","author":"A Belotti","year":"2021","unstructured":"Belotti, A. et al. Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry. Cancer Med. 10, 5859\u20135865. https:\/\/doi.org\/10.1002\/cam4.4136 (2021).","journal-title":"Cancer Med."},{"key":"3496_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07687-2","author":"T Terao","year":"2021","unstructured":"Terao, T. et al. Total diffusion volume in MRI vs total lesion glycolysis in PET\/CT for tumor volume evaluation of multiple myeloma. Eur. Radiol. https:\/\/doi.org\/10.1007\/s00330-021-07687-2 (2021).","journal-title":"Eur. Radiol."},{"key":"3496_CR11","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.7150\/thno.33289","volume":"9","author":"L Rasche","year":"2019","unstructured":"Rasche, L. et al. Lack of spleen signal on diffusion weighted mri is associated with high tumor burden and poor prognosis in multiple myeloma: A link to extramedullary hematopoiesis?. Theranostics 9, 4756\u20134763. https:\/\/doi.org\/10.7150\/thno.33289 (2019).","journal-title":"Theranostics"},{"key":"3496_CR12","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/s1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538-548. https:\/\/doi.org\/10.1016\/s1470-2045(14)70442-5 (2014).","journal-title":"Lancet Oncol."},{"key":"3496_CR13","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/s1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar, S. et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 17, e328\u2013e346. https:\/\/doi.org\/10.1016\/s1470-2045(16)30206-6 (2016).","journal-title":"Lancet Oncol."},{"key":"3496_CR14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1182\/blood-2011-09-379164","volume":"119","author":"K Neben","year":"2012","unstructured":"Neben, K. et al. Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Blood 119, 940\u2013948. https:\/\/doi.org\/10.1182\/blood-2011-09-379164 (2012).","journal-title":"Blood"},{"key":"3496_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2013.088211","volume":"99","author":"G An","year":"2014","unstructured":"An, G. et al. Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value. Haematologica 99, 353\u2013359. https:\/\/doi.org\/10.3324\/haematol.2013.088211 (2014).","journal-title":"Haematologica"},{"key":"3496_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229607","volume":"15","author":"M Takasu","year":"2020","unstructured":"Takasu, M. et al. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI. PLoS ONE 15, e0229607. https:\/\/doi.org\/10.1371\/journal.pone.0229607 (2020).","journal-title":"PLoS ONE"},{"key":"3496_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1148\/radiol.2521081195","volume":"252","author":"T Uto","year":"2009","unstructured":"Uto, T. et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 252, 247\u2013254. https:\/\/doi.org\/10.1148\/radiol.2521081195 (2009).","journal-title":"Radiology"},{"key":"3496_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transplant"},{"key":"3496_CR19","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/jco.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington, S. F. et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J. Clin. Oncol. 32, 3048\u20133058. https:\/\/doi.org\/10.1200\/jco.2013.53.5229 (2014).","journal-title":"J. Clin. Oncol."},{"key":"3496_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13244-016-0492-7","volume":"7","author":"JC Dutoit","year":"2016","unstructured":"Dutoit, J. C. & Verstraete, K. L. MRI in multiple myeloma: A pictorial review of diagnostic and post-treatment findings. Insights Imag. 7, 553\u2013569. https:\/\/doi.org\/10.1007\/s13244-016-0492-7 (2016).","journal-title":"Insights Imag."},{"key":"3496_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00259-002-1106-9","volume":"30","author":"I Buchmann","year":"2003","unstructured":"Buchmann, I. et al. A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250\/183 and (99m)Tc-anti-CD45 mAb YTH 245 with regard to suitability for myeloablative radioimmunotherapy. Eur. J. Nucl. Med. Mol. Imag. 30, 667\u2013673. https:\/\/doi.org\/10.1007\/s00259-002-1106-9 (2003).","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"3496_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1600-0609.2011.01698.x","volume":"87","author":"BA Guinn","year":"2011","unstructured":"Guinn, B. A., Bosslet, K., Lee, C., Richardson, D. & Orchard, K. Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma. Eur. J. Haematol. 87, 554\u2013555. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01698.x (2011).","journal-title":"Eur. J. Haematol."},{"key":"3496_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ajh.20509","volume":"81","author":"E Rumi","year":"2006","unstructured":"Rumi, E. et al. Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia. Am. J. Hematol. 81, 124\u2013127. https:\/\/doi.org\/10.1002\/ajh.20509 (2006).","journal-title":"Am. J. Hematol."},{"key":"3496_CR24","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1182\/blood.V106.11.5073.5073","volume":"106","author":"D Richardson","year":"2005","unstructured":"Richardson, D., Hodges, E., Mani, A. & Orchard, K. CD66 expression on malignant and normal plasma cells: A potential target for therapy. Blood 106, 5073\u20135073. https:\/\/doi.org\/10.1182\/blood.V106.11.5073.5073 (2005).","journal-title":"Blood"},{"key":"3496_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1365-2141.2010.08100.x","volume":"149","author":"C Lee","year":"2010","unstructured":"Lee, C., Guinn, B. A., Brooks, S. E., Richardson, D. & Orchard, K. CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?. Br. J. Haematol. 149, 795\u2013796. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08100.x (2010).","journal-title":"Br. J. Haematol."},{"key":"3496_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1600-0609.2010.01529.x","volume":"85","author":"K Josef","year":"2010","unstructured":"Josef, K., Heidi, M., Robert, P., Pavel, K. & Marek, T. Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma. Eur. J. Haematol. 85, 496\u2013501. https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01529.x (2010).","journal-title":"Eur. J. Haematol."},{"key":"3496_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00259-014-2983-4","volume":"42","author":"T Derlin","year":"2015","unstructured":"Derlin, T. et al. Assessment of bone marrow inflammation in patients with myelofibrosis: An 18F-fluorodeoxyglucose PET\/CT study. Eur. J. Nucl. Med. Mol. Imag. 42, 696\u2013705. https:\/\/doi.org\/10.1007\/s00259-014-2983-4 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"3496_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1259\/bjr\/31542964","volume":"85","author":"SS Saboo","year":"2012","unstructured":"Saboo, S. S. et al. Spleen in haematological malignancies: Spectrum of imaging findings. Br. J. Radiol. 85, 81\u201392. https:\/\/doi.org\/10.1259\/bjr\/31542964 (2012).","journal-title":"Br. J. Radiol."},{"key":"3496_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02673","author":"SF Brynjolfsson","year":"2018","unstructured":"Brynjolfsson, S. F. et al. Long-lived plasma cells in mice and men. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.02673 (2018).","journal-title":"Front. Immunol."},{"key":"3496_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1182\/blood.V8.8.755.755","volume":"8","author":"HD Shapiro","year":"1953","unstructured":"Shapiro, H. D. & Watson, R. J. Splenic aspirations in multiple myeloma. Blood 8, 755\u2013759 (1953).","journal-title":"Blood"},{"key":"3496_CR31","first-page":"275","volume":"22","author":"T Takahara","year":"2004","unstructured":"Takahara, T. et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display. Radiat. Med. 22, 275\u2013282 (2004).","journal-title":"Radiat. Med."},{"key":"3496_CR32","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00330-008-0968-z","volume":"18","author":"TC Kwee","year":"2008","unstructured":"Kwee, T. C., Takahara, T., Ochiai, R., Nievelstein, R. A. J. & Luijten, P. R. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur. Radiol. 18, 1937\u20131952. https:\/\/doi.org\/10.1007\/s00330-008-0968-z (2008).","journal-title":"Eur. Radiol."},{"key":"3496_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/jco.2014.57.9961","volume":"33","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos, M. A. et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: A consensus statement. J. Clin. Oncol. 33, 657\u2013664. https:\/\/doi.org\/10.1200\/jco.2014.57.9961 (2015).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03496-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:59:05Z","timestamp":1670090345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-03496-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-03496-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"19 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23978"}}